Opo Bio Aotearoa

Opo Bio Aotearoa is a New Zealand biotechnology startup that develops cell lines and next-generation bio-based ingredients. According to its official website, the company builds a multi-species and multi-cell type bank of products for research and commercial use, with a focus on cell line development for the cultivated meat industry. Its technology portfolio spans synthetic biology and biomanufacturing, and the company states that its biomaterials are designed to outperform alternatives in performance, sustainability and safety. The company's cell line technology was developed over more than ten years of research at The University of Auckland, giving Opo a track record in biotech leadership through its pioneering cell line portfolio. Opo supplies multi-species cell banks to a global customer base in biotech ingredients, and its next frontier is Opo-Collagen, a bio-based collagen product for cosmetic and medical applications. The company positions itself as a specialist in cell line research and development, allowing partners to focus on other parts of the cultivation process. Opo Bio Aotearoa is privately held and operates from Auckland, New Zealand, serving both research and commercial customers worldwide. Its business spans two main areas: providing cell lines and cell banks for cultivated meat and biotech research, and developing bio-based collagen ingredients. The company invites potential customers to get in touch for collagen samples and to purchase cells through its website.

Opo Bio Aotearoa is a New Zealand startup company in the biotechnology sector. Its cell line technology was developed during more than ten years of research at The University of Auckland, according to the company's official website. This research foundation led to the establishment of Opo as a commercial entity focused on cell line development and bio-based ingredients. The company initially built its business around a pioneering cell line portfolio, creating multi-species cell banks available for research and commercial use. It serves a global customer base in biotech ingredients and has positioned itself as a supplier to the cultivated meat industry, helping partners scale through cell line development. More recently, Opo has expanded its focus toward next-generation bio-based ingredients for cosmetic and medical applications. Its next frontier is Opo-Collagen, a collagen product developed using its synthetic biology and biomanufacturing technology portfolio. The company continues to build a multi-species and multi-cell type bank of products and invites potential customers to request collagen samples and purchase cells through its website.

• Cell line technology developed over more than ten years of research at The University of Auckland

• Opo Bio Aotearoa established as a New Zealand startup company

• Multi-species cell banks made available for research and commercial use

• Opo-Collagen announced as next frontier product for cosmetic and medical applications

Specialist in cell line research and development, providing high-performance bio-based ingredients for cultivated meat, cosmetics and medical applications.

• Multi-species cell banks

  Cell banks available for research and commercial use, built as part of a multi-species and multi-cell type product bank.

• Cell lines for cultivated meat

  Cell line development for the cultivated meat industry, helping partners scale through supply chain partnerships.

• Opo-Collagen

  Next-generation bio-based collagen for cosmetic and medical applications, developed using synthetic biology and biomanufacturing.

1. 1Opo Bio Aotearoa | Experts in cell line research and developmentopobio.com
2. 2Opo Bio Aotearoa - Wikidatawikidata.org